Neuberger Berman Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-692
| Closed | -$229K | – | 2094 |
|
|
2025
Q1 | $229K | Sell |
692
-21,436
| -97% | -$7.1M | ﹤0.01% | 1779 |
|
|
2024
Q4 | $6.83M | Buy |
+22,128
| New | +$6.83M | 0.01% | 885 |
|
|
2023
Q4 | – | Sell |
-6,817
| Closed | -$996K | – | 1896 |
|
|
2023
Q3 | $996K | Buy |
+6,817
| New | +$996K | ﹤0.01% | 1257 |
|
|
2013
Q4 | – | Sell |
-39,415
| Closed | -$249K | – | 1641 |
|
|
2013
Q3 | $249K | Sell |
39,415
-1,500
| -4% | -$9.48K | ﹤0.01% | 1457 |
|
|
2013
Q2 | $204K | Buy |
+40,915
| New | +$204K | ﹤0.01% | 1490 |
|